Disposition of levobupivacaine during intraoperative continuous caudal epidural analgesia in a preterm neonate

. 2024 Mar ; 168 (1) : 81-84. [epub] 20231122

Jazyk angličtina Země Česko Médium print-electronic

Typ dokumentu kazuistiky, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid37997373

BACKGROUND: Continuous caudal epidural analgesia used intraoperatively in children is an effective and safe technique. However, in preterm neonates, developmental factors may significantly affect levobupivacaine disposition, leading to variable pharmacokinetics, pharmacodynamics, and potential large-variable systemic toxicity of local anesthetics. OBJECTIVE: To our knowledge, this is the first case report describing the disposition of levobupivacaine used for intraoperative caudal epidural analgesia in a preterm neonate treated for the postoperative pain profile. METHOD: 4-days old neonate (postmenstrual age 35+5, weight 2140 g) with congenital anal atresia received continuous caudal epidural long-term analgesia (loading dose 1.694 mg/kg, initial infusion 0.34 mg/kg/hour) before correction surgery. The blood samples were obtained at 1.0, 1.5, 6.5, 12, and 36.5 h after the start of epidural infusion. The pharmacokinetic profile of levobupivacaine was determined by using the Stochastic Approximation Expectation Maximization algorithm. COMFORT and NIPS pain scores were used for the assessment of epidural analgesia. RESULTS: The levobupivacaine absorption rate constant, apparent volume of distribution, apparent clearance, and elimination half-life were 10.8 h-1, 0.9 L, 0.086 L/h, and 7.3 h, respectively. CONCLUSION: The results confirm our hypothesis of altered pharmacokinetics in the preterm neonate. Therefore, levobupivacaine therapy in these patients should be carefully monitored. Since therapeutic drug monitoring of levobupivacaine is not established in clinical routines, we suggest monitoring the intraoperative pain profile using validated scores. TRIAL REGISTRATION: EudraCT number: 2020-000595-37.

Zobrazit více v PubMed

Wiegele M, Marhofer P, Lönnqvist PA. Caudal epidural blocks in paediatric patients: a review and practical considerations. Br J Anaesth 2019;122(4):509-17. DOI

Anell-Olofsson M, Lönnqvist PA, Bitkover C, Lundeberg S, Larsson BA, Eksborg S, Bartocci M. Plasma concentrations of levobupivacaine associated with two different intermittent wound infusion regimens following surgical ductus ligation in preterm infants. Paediatr Anaesth 2015;25(7):711-8. DOI

Adler AC, Yim MM, Chandrakantan A. Erector spinae plane catheter for neonatal thoracotomy: a potentially safer alternative to a thoracic epidural. Can J Anaesth 2019;66(5):607-8. DOI

Bosenberg A, Flick RP. Regional anesthesia in neonates and infants. Clin Perinatol 2013;40(3):525-38. DOI

Mixa V, Nedomova B, Berka I. Continuous epidural analgesia, a new prospect in analgesia of newborns. Bratisl Lek Listy 2015;116(9):571-3. DOI

Oda Y. Pharmacokinetics and systemic toxicity of local anesthetics in children. J Anesth 2016;30(4):547-50. DOI

El-Boghdadly K, Pawa A, Chin KJ. Local anesthetic systemic toxicity: current perspectives. Local Reg Anesth 2018;11:35-44. DOI

Dontukurthy S, Tobias JD. Update on Local Anesthetic Toxicity, Prevention and Treatment During Regional Anesthesia in Infants and Children. J Pediatr Pharmacol Ther 2021;26(5):445-54. PubMed DOI

Mazoit JX, Dalens BJ. Pharmacokinetics of local anaesthetics in infants and children. Clin Pharmacokinet 2004;43(1):17-32. PubMed DOI

Chalkiadis GA, Anderson BJ, Tay M, Bjorksten A, Kelly JJ. Pharmacokinetics of levobupivacaine after caudal epidural administration in infants less than 3 months of age. Br J Anaesth 2005;95(4):524-9. PubMed DOI

Chalkiadis GA, Anderson BJ. Age and size are the major covariates for prediction of levobupivacaine clearance in children. Paediatr Anaesth 2006;16(3):275-82. PubMed DOI

Allegaert K, Palmer GM, Anderson BJ. The pharmacokinetics of intravenous paracetamol in neonates: size matters most. Arch Dis Child 2011;96(6):575-80. DOI

Hammer GB, Maxwell LG, Taicher BM, Visoiu M, Cooper DS, Szmuk P, Pheng LH, Gosselin NH, Lu J, Devarakonda K. Randomized Population Pharmacokinetic Analysis and Safety of Intravenous Acetaminophen for Acute Postoperative Pain in Neonates and Infants. J Clin Pharmacol 2020;60(1):16-27. DOI

Howie SR. Blood sample volumes in child health research: review of safe limits. Bull World Health Organ 2011;89(1):46-53. DOI

Wielenga JM, De Vos R, de Leeuw R, De Haan RJ. COMFORT scale: a reliable and valid method to measure the amount of stress of ventilated preterm infants. Neonatal Netw 2004; 23(2):39-44. PubMed DOI

Kokki H, Ylönen P, Heikkinen M, Reinikainen M. Levobupivacaine for pediatric spinal anesthesia. Anesth Analg 2004;98(1):64-7. PubMed DOI

Frawley GP, Farrell T, Smith S. Levobupivacaine spinal anesthesia in neonates: a dose range finding study. Paediatr Anaesth 2004;14(10):838-44. PubMed DOI

Bajwa SJ, Kaur J. Clinical profile of levobupivacaine in regional anesthesia: A systematic review. J Anaesthesiol Clin Pharmacol 2013;29(4):530-9. DOI

Vashisht R, Bendon AA, Okonkwo I, Patel D, Fullwood C, Ogungbenro K, Aarons L, Darwich AS. A study of the dosage and duration for levobupivacaine infusion by the caudal-epidural route in infants aged 3-6 months. Paediatr Anaesth 2019;29(2):161-8. PubMed DOI

Bardsley H, Gristwood R, Baker H, Watson N, Nimmo W. A comparison of the cardiovascular effects of levobupivacaine and rac-bupivacaine following intravenous administration to healthy volunteers. Br J Clin Pharmacol 1998;46(3):245-9. DOI

Heppolette CAA, Brunnen D, Bampoe S, Odor PM. Clinical Pharmacokinetics and Pharmacodynamics of Levobupivacaine. Clin Pharmacokinet 2020;59(6):715-45. PubMed DOI

Sipek J, Pokorna P, Sima M, Berka I, Hlozek T, Styblova J, Mixa V, Nedomova B. Plasma concentrations of levobupivacaine in neonates during caudal epidural analgesia maintained over 48 hours. Bratisl Lek Listy 2023;124(2):116-20. DOI

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...